ChangesInterviews New ways to assess new drug treatments? The centralised negotiation on some drugs needed during the Covid-19 crisis reignited the debate around whether each Member State should continue to act independently on such mattersInterview with Claudio JommigiadaApril 2021
It happensInterviews Changes to the organisation of the Italian National Healthcare System (SSN) after covid-19 How will national agencies help us?Interview with Domenico Mantoan edited by Antonio Addis giadaDecember 2020
PriorityInterviews Health Technology Assessment for priority setting: what do we need? Do we need a global look or attention that focuses on the contexts where decisions will have an impact?Interview with Kalipso ChalkidougiadaDecember 2018